Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
思晔投资(上海思晔投资管理有限公司)是一家成立于2013年的中国私募基金公司,专注于多资产、多策略的证券类私募基金管理。公司由张晔创立并领导,注册资本3000万元人民币,实缴比例30%。目前管理16只基金,总规模在50-100亿元人民币之间。代表产品包括“思晔晨风1号”。该公司以多元化金融背景团队为特色,并无公开披露涉及生命科学、医药或生物技术领域的直接业务。[1][2][3][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 思晔投资.